|
1
|
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
|
Eur Heart J
|
2005
|
6.86
|
|
2
|
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.
|
Eur Heart J
|
2006
|
5.79
|
|
3
|
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
|
N Engl J Med
|
2003
|
2.92
|
|
4
|
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla.
|
J Am Coll Cardiol
|
2012
|
2.38
|
|
5
|
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.
|
Clin J Am Soc Nephrol
|
2007
|
2.22
|
|
6
|
Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis.
|
Circulation
|
2003
|
1.91
|
|
7
|
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.
|
Eur Heart J
|
2011
|
1.82
|
|
8
|
Myocardial blood flow measurement by PET: technical aspects and clinical applications.
|
J Nucl Med
|
2005
|
1.74
|
|
9
|
The case for myocardial ischemia in hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2009
|
1.66
|
|
10
|
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.
|
J Am Coll Cardiol
|
2006
|
1.65
|
|
11
|
Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
|
Circ Cardiovasc Imaging
|
2009
|
1.61
|
|
12
|
Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans.
|
Circulation
|
2004
|
1.59
|
|
13
|
Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation.
|
J Nucl Med
|
2002
|
1.57
|
|
14
|
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis.
|
Am J Kidney Dis
|
2006
|
1.49
|
|
15
|
Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.
|
J Am Coll Cardiol
|
2007
|
1.47
|
|
16
|
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
|
J Am Coll Cardiol
|
2013
|
1.44
|
|
17
|
Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: Implications for pharmacologic stress testing in coronary artery disease.
|
J Nucl Cardiol
|
2006
|
1.39
|
|
18
|
Patent foramen ovale closure and brain ischaemic lesions.
|
Heart
|
2013
|
1.39
|
|
19
|
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries.
|
Circulation
|
2002
|
1.36
|
|
20
|
Coronary microvascular dysfunction: an update.
|
Eur Heart J
|
2013
|
1.28
|
|
21
|
Program of cell survival underlying human and experimental hibernating myocardium.
|
Circ Res
|
2004
|
1.27
|
|
22
|
Coronary microvascular resistance: methods for its quantification in humans.
|
Basic Res Cardiol
|
2009
|
1.26
|
|
23
|
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.
|
Eur Heart J
|
2009
|
1.26
|
|
24
|
Cardiac sympathetic imaging with mIBG in heart failure.
|
JACC Cardiovasc Imaging
|
2010
|
1.19
|
|
25
|
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2006
|
1.13
|
|
26
|
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
|
Eur Heart J
|
2009
|
1.12
|
|
27
|
Respiratory gating of cardiac PET data in list-mode acquisition.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.10
|
|
28
|
Evaluation of the microcirculation in hypertension and cardiovascular disease.
|
Eur Heart J
|
2007
|
1.09
|
|
29
|
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.
|
Eur Heart J
|
2012
|
1.08
|
|
30
|
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.07
|
|
31
|
Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment?
|
J Am Coll Cardiol
|
2014
|
1.06
|
|
32
|
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography.
|
J Am Coll Cardiol
|
2010
|
1.05
|
|
33
|
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
|
J Am Coll Cardiol
|
2011
|
1.03
|
|
34
|
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
|
Diabetes
|
2002
|
1.00
|
|
35
|
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
|
JACC Cardiovasc Imaging
|
2013
|
0.97
|
|
36
|
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
|
J Cardiovasc Transl Res
|
2009
|
0.95
|
|
37
|
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome.
|
Circulation
|
2004
|
0.93
|
|
38
|
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC].
|
Kardiol Pol
|
2005
|
0.93
|
|
39
|
Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease.
|
J Am Coll Cardiol
|
2002
|
0.91
|
|
40
|
Assessment of myocardial ischaemia and viability: role of positron emission tomography.
|
Eur Heart J
|
2010
|
0.91
|
|
41
|
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.
|
J Nucl Med
|
2008
|
0.91
|
|
42
|
Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation.
|
J Nucl Med
|
2006
|
0.91
|
|
43
|
Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.90
|
|
44
|
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.90
|
|
45
|
Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure.
|
Eur Heart J
|
2010
|
0.90
|
|
46
|
Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT.
|
J Nucl Med
|
2010
|
0.90
|
|
47
|
123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.
|
J Nucl Cardiol
|
2009
|
0.89
|
|
48
|
Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months.
|
J Am Coll Cardiol
|
2002
|
0.89
|
|
49
|
Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction?
|
Circ J
|
2010
|
0.88
|
|
50
|
Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance.
|
J Nucl Med
|
2002
|
0.87
|
|
51
|
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
|
Am J Physiol Endocrinol Metab
|
2002
|
0.86
|
|
52
|
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
|
Int J Cardiol
|
2008
|
0.86
|
|
53
|
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.85
|
|
54
|
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension.
|
J Hypertens
|
2011
|
0.84
|
|
55
|
Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease.
|
J Nucl Med
|
2005
|
0.84
|
|
56
|
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium.
|
Basic Res Cardiol
|
2002
|
0.83
|
|
57
|
Impairment of coronary flow reserve in aortic stenosis.
|
J Appl Physiol (1985)
|
2008
|
0.83
|
|
58
|
Pre- and post-synaptic sympathetic function in human hibernating myocardium.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.83
|
|
59
|
A novel (18)F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography: another way to avoid the need of an on-site cyclotron.
|
Circ Cardiovasc Imaging
|
2009
|
0.82
|
|
60
|
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences.
|
Ital Heart J
|
2004
|
0.82
|
|
61
|
Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat.
|
Basic Res Cardiol
|
2012
|
0.82
|
|
62
|
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.82
|
|
63
|
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.82
|
|
64
|
Is central nervous system processing altered in patients with heart failure?
|
Eur Heart J
|
2004
|
0.81
|
|
65
|
Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study.
|
J Renin Angiotensin Aldosterone Syst
|
2003
|
0.81
|
|
66
|
Hypertrophic cardiomyopathy: The need for randomized trials.
|
Glob Cardiol Sci Pract
|
2013
|
0.80
|
|
67
|
[Guidelines on the management of stable angina pectoris. Executive summary].
|
Rev Esp Cardiol
|
2006
|
0.80
|
|
68
|
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia?
|
Eur Heart J
|
2007
|
0.79
|
|
69
|
Methods to investigate coronary microvascular function in clinical practice.
|
J Cardiovasc Med (Hagerstown)
|
2013
|
0.79
|
|
70
|
Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
|
J Heart Lung Transplant
|
2004
|
0.79
|
|
71
|
Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.78
|
|
72
|
Cardiac nociception.
|
Circulation
|
2006
|
0.78
|
|
73
|
Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2006
|
0.78
|
|
74
|
Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum.
|
Biochem Biophys Res Commun
|
2009
|
0.78
|
|
75
|
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses.
|
Am J Physiol Heart Circ Physiol
|
2007
|
0.78
|
|
76
|
[Guidelines for percutaneous coronary interventions].
|
Rev Esp Cardiol
|
2005
|
0.77
|
|
77
|
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.
|
J Nucl Cardiol
|
2009
|
0.77
|
|
78
|
The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure.
|
J Hypertens
|
2014
|
0.77
|
|
79
|
Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction.
|
Basic Res Cardiol
|
2002
|
0.77
|
|
80
|
Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study.
|
J Cardiovasc Pharmacol
|
2006
|
0.77
|
|
81
|
[Guidelines for percutaneous coronary interventions].
|
Ital Heart J Suppl
|
2005
|
0.77
|
|
82
|
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris].
|
Kardiol Pol
|
2006
|
0.77
|
|
83
|
Absolute figures are better than percentages.
|
JACC Cardiovasc Imaging
|
2009
|
0.77
|
|
84
|
Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.77
|
|
85
|
[Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse form of the disease].
|
G Ital Cardiol (Rome)
|
2014
|
0.76
|
|
86
|
Coronary microvascular dysfunction in patients with cardiomyopathies.
|
Circ Heart Fail
|
2008
|
0.76
|
|
87
|
Positron emission tomography for quantitation of myocardial perfusion.
|
J Nucl Cardiol
|
2004
|
0.76
|
|
88
|
Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis.
|
Int J Cardiol
|
2013
|
0.76
|
|
89
|
Myocardial viability in ischemic left ventricular dysfunction.
|
N Engl J Med
|
2011
|
0.76
|
|
90
|
From Left Ventricular Hypertrophy to Dysfunction and Failure.
|
Circ J
|
2016
|
0.76
|
|
91
|
A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
92
|
Myocardial ischaemia and metabolic memory.
|
Eur J Nucl Med Mol Imaging
|
2006
|
0.75
|
|
93
|
Risk stratification of patients with normal myocardial perfusion imaging: help comes from the periphery.
|
Eur Heart J
|
2013
|
0.75
|
|
94
|
Molecular imaging of vascular inflammation.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.75
|
|
95
|
[An unusual case of transient ST-segment elevation during hypertensive crisis in a patient with left ventricular hypertrophy].
|
G Ital Cardiol (Rome)
|
2012
|
0.75
|
|
96
|
Calcified left ventricular endomyocardial fibrosis.
|
J Heart Valve Dis
|
2012
|
0.75
|
|
97
|
Introduction IJC Special Issue on Sudden Cardiac Death.
|
Int J Cardiol
|
2017
|
0.75
|
|
98
|
Reduction of Circulating HLA-DR(+) T Cell Levels Correlates With Increased Carotid Intraplaque Neovascularization and Atherosclerotic Burden.
|
JACC Cardiovasc Imaging
|
2016
|
0.75
|
|
99
|
["African sickness" and the heart: the mystery of endomyocardial fibrosis].
|
G Ital Cardiol (Rome)
|
2011
|
0.75
|
|
100
|
An accordion not to be played.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
101
|
Hibernation and congestive heart failure.
|
Heart Fail Rev
|
2003
|
0.75
|
|
102
|
Renal denervation in a patient with two renal accessory arteries: a case report.
|
Blood Press
|
2013
|
0.75
|
|
103
|
An accordion not to be played.
|
J Cardiovasc Med (Hagerstown)
|
2015
|
0.75
|
|
104
|
[Guidelines on the management of stable angina pectoris: executive summary].
|
G Ital Cardiol (Rome)
|
2006
|
0.75
|
|
105
|
[Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve].
|
Ital Heart J Suppl
|
2003
|
0.75
|
|
106
|
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention].
|
G Ital Cardiol (Rome)
|
2014
|
0.75
|
|
107
|
[Intra-arterial thrombolysis facilitated by ultrasound in submassive pulmonary embolism: first documented case report in Italy].
|
G Ital Cardiol (Rome)
|
2013
|
0.75
|
|
108
|
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia?
|
Ital Heart J
|
2002
|
0.75
|
|
109
|
[Revascularization of the hibernated myocardium: a clinical problem still unsolved].
|
G Ital Cardiol (Rome)
|
2012
|
0.75
|
|
110
|
Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis - limited vs. diffuse form.
|
Circ J
|
2015
|
0.75
|